Intranet PAC-CI
Published on 20 Nov 2024

Grand-Bassam: Workshop for EBO-PEP consortium partners to define the strategy for implementing the EBO-PEP clinical trial.

PAC-CI

Researcher, PAC-CI

1132 Views
Grand-Bassam: Workshop for EBO-PEP consortium partners to define the strategy for implementing the EBO-PEP clinical trial.

Summary & Key Points

"EBO-PEP is a consortium of partners aiming to expand the portfolio of therapeutic tools against MVE by evaluating a PPE strategy for high-risk contacts and maintaining a network for sharing knowledge and collaboration around PPE."

EBO-PEP is a consortium of partners whose goal is to expand the portfolio of therapeutic tools against EVD by evaluating a PEP strategy for high-risk contacts and maintaining a knowledge-sharing and collaboration network around PEP.

In implementing the project, experts will conduct a clinical trial in Africa to test the efficacy of treatments used as PEP for high-risk contacts; strengthen the capacity of clinical researchers and increase community knowledge of Ebola virus research; and define the best PEP strategy for high-risk contacts and advocate for the implementation of PEP in Ebola virus disease-affected countries.

For this collaborative workshop held at the Hôtel Assoyam in Grand-Bassam from September 10 to 13, 2024, partners from France (INSERM (iPLesp, ANRS-MIE), University of Bordeaux, ALIMA, PANTHER), the DRC (INRB), Spain (ISGLOBAL), Belgium (Médecins Sans Frontières), Senegal (Cheikh Anta Diop University), Côte d’Ivoire (PAC-CI Program), and Guinea (ANSS, CERFIG) met to finalize the protocol and discuss the implementation of the EBO-PEP study.

Several presentations were given, followed by discussions on the clinical trial protocol and the activities of the various working groups. These working groups focus on overall project coordination, scientific coordination, project preparation, clinical trial management, health economics, community engagement, and study acceptability among target populations.

In addition, participants discussed key factors for project success, including governance of the EBO-PEP consortium, governance of the EBO-PEP project, and the timeline to facilitate implementation.

The next meetings are scheduled for September and December 2024 to finalize the protocol, establish the scientific advisory board and independent monitoring committee, and submit the project.

Participants left very satisfied with the results of the work, the atmosphere of the workshop, and the opportunity for some to discover Grand-Bassam, one of Côte d’Ivoire’s tourist treasures.

PAC-CI

Clinical Research Associate and Communications Manager at PAC-CI

Contact the author

Related Articles